Anesthesia Management of Retroperitoneal Adrenalectomies

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by Kliniken Essen-Mitte.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Kliniken Essen-Mitte
ClinicalTrials.gov Identifier:
NCT00894335
First received: May 6, 2009
Last updated: June 27, 2011
Last verified: May 2009

May 6, 2009
June 27, 2011
May 2008
March 2012   (final data collection date for primary outcome measure)
Arterial-alveolar Carbon dioxide Difference [ Time Frame: 3 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00894335 on ClinicalTrials.gov Archive Site
Perioperative maximal mean arterial pressure [ Time Frame: 3 Years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Anesthesia Management of Retroperitoneal Adrenalectomies
Anesthesiological Management of Hemodynamics and Gas Exchange for Retroperitoneal Adrenalectomies

This study is a prospective, perioperative evaluation of hemodynamic and respiratory parameters in patients undergoing retroperitoneoscopic adrenalectomies.

Due to their underlying disease, patients with adrenal tumors are prone to episodes of hyper- and hypotension. Furthermore, excessive hypercarbia and an increased arterial-alveolar CO2 difference can be seen during these operations.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients with adrenal tumors scheduled for retroperitoneal adrenalectomies

Adrenal Tumors
Not Provided
  • 1
    Pheochromocytoma
  • 2
    Conn-Syndrome
  • 3
    Cushing disease
  • 4
    Metastasis
  • 5
    Non-functional tumor
Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery. 2006 Dec;140(6):943-8; discussion 948-50.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
500
July 2012
March 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with an adrenal tumor

Exclusion Criteria:

  • Age below 18 years
Both
18 Years to 90 Years
No
Contact: Harald Groeben, Prof., M.D. ##49 201 174 ext 31109 h.groeben@kliniken-essen-mitte.de
Germany
 
NCT00894335
retroper adrenal
No
Harald Groeben, Prof. Dr., Department of Anesthesiology and CCM , Clinics Essen-Mitte
Kliniken Essen-Mitte
Not Provided
Principal Investigator: Harald Groeben, Prof, M.D. Clinics Essen-Mitte
Kliniken Essen-Mitte
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP